|
KMID : 0918520150150020087
|
|
Journal of the Korean Society of Inherited Metabolic Disease
2015 Volume.15 No. 2 p.87 ~ p.92
|
|
|
A Case of Mucopolysaccharidosis Type 2 Diagnosed Early through Brain MRI
|
|
Lee Yoon-Kyoung
Cho Sung-Yoon
Kim Jin-Sup
Huh Rimm
Jin Dong-Kyu
|
|
|
Abstract
|
|
|
|
Mucopolysaccharidosis (MPS) is an inherited disease entity associated with lysosomal enzyme deficiencies. MPS type 2, also known as Hunter syndrome, has a characteristic morphology primarily involving x-l inked recessive defects and iduronate-2-sulfatase gene mutation. The purpose of this case report is to provide important clues to help pediatricians identify Hunter syndrome patients earlier (i.e., before the disease progresses). A 30-month-old boy showed developmental delay and decreased speech ability. Physical examinations revealed a flat nose and extensive Mongolian spots. Brain magnetic resonance images (MRIs) showed bilateral multiple patchy T2 hyperintense lesions in the periventricular and deep white matter, several cyst-like lesions in the body of the corpus callosum, and diffuse brain atrophy, which were in keeping with the diagnosis. Based on these findings, the patient was suspected of having MPS. In the laboratory findings, although the genetic analysis of IDS (Iduronate-2-sulfatase) did not show any pathogenic variant, the enzymatic activity of IDS was not detected. We could confirm the diagnosis of MPS, because other sulfatases, such as α-L-iduronidase, were detected in the normal range. Early enzymatic replacement therapy is essential and has a relatively good prognosis. Therefore, early diagnosis should be made before organ damage becomes irreversible, and brain MRIs can provide additional diagnostic clues to help distinguish the disorder.
|
|
|
KEYWORD
|
|
|
Mucopolysaccharidosis type 2, Iduronate-2-sulfatase, Brain MRI, Developmental delay
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|